Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A Randomized Phase II Study of Tosedostat in Combination with Either Cytarabine or Decitabine in Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Blood (2014)
  • Raya Mawad, Fred Hutchinson Cancer Research Center
  • Pamela S. Becker, Fred Hutchinson Cancer Research Center
  • Paul C. Hendrie, Fred Hutchinson Cancer Research Center
  • Bart L Scott, Fred Hutchinson Cancer Research Center
  • Brent L. Wood, Fred Hutchinson Cancer Research Center
  • Carol Dean, Fred Hutchinson Cancer Research Center
  • Vicky Sandhu, Fred Hutchinson Cancer Research Center
  • H. Joachim Deeg, Fred Hutchinson Cancer Research Center
  • Roland B. Walter, Fred Hutchinson Cancer Research Center
  • Lixia Wang, Eli Lilly and Company
  • Jack Singer, University of Washington
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
  • John Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
December 6, 2014
Citation Information
Raya Mawad, Pamela S. Becker, Paul C. Hendrie, Bart L Scott, et al.. "A Randomized Phase II Study of Tosedostat in Combination with Either Cytarabine or Decitabine in Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome" Blood Vol. 124 Iss. 21 (2014) p. 3690 - 3690
Available at: http://works.bepress.com/john-pagel/89/